New combined treatment shows promise in hepatocellular carcinoma
Researchers from the Metabolism and Cancer group at the Bellvitge Biomedical Research Institute (IDIBELL), led…
Browsing: mTOR inhibitors
Combined therapies increase adverse side effects for patients with advanced hormone receptor-positive breast cancer
Patients with advanced breast cancer who are treated with a combination of drugs that target…